Application

18181640 · Human Anti-VEGFR-2/KDR Antibodies

Filed 2023-03-10 · Granted · Patent 12636362 (2026-05-26) The official file ↗The patent and its PDF ↗ · Art unit 1646 · Examiner Hong Sang Typical · CPC A61K 39/3955 · Kadmon Corporation, LLC · Sanofi/McNeill PLLC

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

24.1 mo

to disposition 38.5 mo

Statutes raised

102 103

2 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.